{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:35:34Z","timestamp":1790271334685,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jinf.2021.07.003","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T03:01:44Z","timestamp":1625886104000},"page":"94-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["N-acetylcysteine for the treatment of COVID-19 among hospitalized patients"],"prefix":"10.1016","volume":"84","author":[{"given":"Sergey N.","family":"Avdeev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viliya V.","family":"Gaynitdinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zamira M.","family":"Merzhoeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelimkhan G.-M.","family":"Berikkhanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jinf.2021.07.003_bib0001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"10285","key":"10.1016\/j.jinf.2021.07.003_bib0002","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (recovery): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jinf.2021.07.003_bib0003","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jinf.2021.05.011","article-title":"Secukinumab in severe COVID-19 pneumonia: does it have a clinical impact?","volume":"83","author":"Hasan","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2021.07.003_bib0004","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2020.8247","article-title":"N-Acetylcysteine and hydrogen sulfide in Coronavirus disease 2019","author":"Bourgonje","year":"2021","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"10.1016\/j.jinf.2021.07.003_bib0005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/SHK.0000000000001562","article-title":"Serum hydrogen sulfide and outcome association in pneumonia by the SARS-CoV-2 coronavirus","volume":"54","author":"Renieris","year":"2020","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.jinf.2021.07.003_bib0006","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/ajrccm.152.3.7663783","article-title":"Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals","volume":"152","author":"Meyer","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jinf.2021.07.003_bib0007","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","article-title":"N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why","volume":"52","author":"Aldini","year":"2018","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jinf.2021.07.003_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108544","article-title":"Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine","volume":"219","author":"Ibrahim","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jinf.2021.07.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173494","article-title":"Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial","volume":"885","author":"Alamdari","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.jinf.2021.07.003_bib0010","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1093\/cid\/ciaa1443","article-title":"Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19","volume":"72","author":"de Alencar","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321003297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321003297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:33:23Z","timestamp":1759008803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321003297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0163445321003297"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2021.07.003","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetylcysteine for the treatment of COVID-19 among hospitalized patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2021.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}